Next Article in Journal
Effects of Temperature and Salinity on Ovarian Development and Differences in Energy Metabolism Between Reproduction and Growth During Ovarian Development in the Lateolabrax maculatus
Previous Article in Journal
Transgenerational Effects and Heritability of Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorder
Previous Article in Special Issue
Exploring the Relationship Between Brain-Derived Neurotrophic Factor Haplotype Variants, Personality, and Nicotine Usage in Women
 
 
Article
Peer-Review Record

Independence of Peripheral Brain-Derived Neurotrophic Factor from Depression and Anxiety Symptoms in Cocaine Use Disorder: An Initial Description

Int. J. Mol. Sci. 2025, 26(17), 8294; https://doi.org/10.3390/ijms26178294
by Dannia M. Islas-Preciado 1, Ruth Alcalá-Lozano 1,2, Erika P. Aguilar-Velazquez 1, Yvonne G. Flores-Medina 3, Nelly M. Vega-Rivera 4, Erika Estrada-Camarena 4, Ruben Carino-Escobar 5, Jorge J. González-Olvera 3 and Erik D. Morelos-Santana 1,6,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2025, 26(17), 8294; https://doi.org/10.3390/ijms26178294
Submission received: 7 May 2025 / Revised: 29 July 2025 / Accepted: 5 August 2025 / Published: 27 August 2025
(This article belongs to the Special Issue Molecular Insights into Addiction)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The manuscript entitled „Independence of peripheral brain derived neurotrophic factor from depression and anxiety symptoms in cocaine use disorder“ by Islas-Preciado and coworkers estimates the relationship between peripheral BDNF and mood disorders on the basis of cocaine use disorder. The basic idea is good, but I have some serious concerns.

The sample size is low.

To rely on peripheral BDNF levels as a single biomarker is very questionable.

BDNF is just one of the neurotrophin system elements:

- The absolute levels of BDNF should be analyzed along with its precursor (proBDNF) since they have the opposite actions, and therefore their ratio is a qualitatively more important indicator (this could be analyzed in peripheral blood samples)

- the beneficial effects of BDNF are achieved via TrkB receptors, so their expression is equally important as BDNF levels (this could also be analyzed in peripheral blood samples)

This manuscript, at this stage, does not meet the criteria for publication. However, with the suggested additional analyses, it can be substantially improved and resubmitted.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Comments to the Authors

Manuscript ID: ijms-3659027

Title: Independence of peripheral brain derived neurotrophic factor from depression and anxiety symptoms in cocaine use disorder.

The Authors aimed to examine the relationship between BDNF peripheral levels and depression and anxiety symptoms in people with CUD. In addition, they aimed to compare BDNF peripheral levels among different severity categories of depression and anxiety symptoms in persons with CUD.

Previous knowledge indicates gender differences in BDNF levels, as well as a relationship between gender and mood. It is also known that sex hormones modulate BDNF expression and function.

According to recent literature, there are clear gender differences in cocaine addiction, and consequently differences in the effects of cocaine use. Twenty-nine people participated in the study, including three women. The study did not take into account gender division, and to obtain reliable results, first of all, a larger group of volunteers is needed.

In my opinion, the manuscript is not ready for printing. In order to obtain reliable results, the authors must increase the group of volunteers, taking into account the division by gender.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

Aside from the authors agreeing with my comments, I don’t see any additional breakthrough considering the quality and novelty presented in the manuscript. Thus, I can only recommend the papers published in Molecular Psychiatry (https://doi.org/10.1038/s41380-023-02367-7) and in Frontiers in Psychiatry (https://doi.org/10.3389/fpsyt.2022.836771) as a direction to improve the research (i.e., manuscript) to meet the high-quality standards of the Journal.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 3

Reviewer 1 Report

Comments and Suggestions for Authors

The authors commented adequately to my remarks.

Author Response

Authors appreciate the reviewer's comments that help to enhance our manuscript. 

Back to TopTop